Navigation Links
IFRS Information - First Half of 2007
Date:9/13/2007

p>

the grounds of materiality.

Fair value adjustments primarily relate to:

- the recognition of intangible assets totaling $3,085.8 million, primarily represented by developed technology in respect of the pediatric indication of VYVANSE in the US ($1,133.3 million) and in-process research and development in respect of VYVANSE for non-pediatric patients in the US and VYVANSE in the RoW ($1,943.3 million);

- deferred tax liabilities of $1,202.4 million in respect of temporary differences relating to recognized intangible assets; and

- elimination of liabilities relating to deferred revenue in respect of the New River Collaboration Agreements, ($62.6 million), sold warrants ($133.0 million) and share based payment liabilities relating to cash settled SARs ($122.9 million).

The goodwill arising on the acquisition of New River primarily results from anticipated operating synergies from the combination.

If the acquisition had been completed on the first day of 2007, Group revenues for the period to June 30, 2007 would have been $1,103.1 million, and the Group's loss before tax from continuing operations would have been $156.6 million. This reflects the results of the combined entity adjusted for financing costs, the amortization of intangible assets and share based compensation costs as if the acquisition completed on January 1, 2007. The results of New River for the six months to June 30, 2007 as included within the pro forma results of the combined entity include a non-recurring charge of $82.8 million relating to New River's cash settled SARs which were extinguished as a result of the acquisition.

The results of the combined entity include the following adjustments:

(i) an adjustment to eliminate the revenues recognized by New River of $3.0 million for the six months to June 30, 2007 in connection with the New River Collaboration Agreements;

(ii) an adjustment to increase interest expense by $25.3 million for
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Imaging and Analysis of DIGE Product Information Sheet, Rev B
2. Study affirms information technology-productivity link
3. TrafficCast integrates new information source
4. Rote education fails the Information Age
5. Weather information companies launch data product
6. TeraMedica launches information manager
7. Global information firm reaches diverse markets
8. Preparing for avian flu with information technology
9. Businesses cant hide personal information losses, theft
10. S.C. Johnson lands in No. 2 spot in Information Week 500 list
11. Crate and Barrel deploys Firstlogics Information Quality Suite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Genedata, a leading provider of advanced ... research, today announced the release of Genedata ... enterprise solution for biologics R&D. This first-in-class workflow ... and development of novel biotherapeutics. Version 5.0 enables ... optimization and developability requirements. Genedata will present highlights ...
(Date:5/4/2015)... May 4, 2015 - New ... med students prepare for the United States Medical Licensing ... of scientific, technical and medical information products and services, ... (Massive Open Online Course) designed to help medical students ... Step 1, the first and most daunting of the ...
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital has ... hand impairments by acquiring the Armeo®Spring arm and ... site. , Secured through grant support of a ... option for patients with upper extremity weakness or ... of just four Illinois providers offering treatment with ...
(Date:5/1/2015)... Pfenex Inc. (NYSE MKT: PFNX), a ... biosimilar therapeutics including high value and difficult to ... 2015 financial results will be released on Thursday, ... 8:30 am Eastern Time, Pfenex management will host ... and provide a business update. A press release outlining ...
Breaking Biology Technology:Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 4Elsevier's Free MOOC Prepares Med Students for Licensing Exam 2Elsevier's Free MOOC Prepares Med Students for Licensing Exam 3Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2
... , May 4 Microfluidics International Corporation (OTC Bulletin Board: MFLU) announced ... 11, 2010 , at 8:30am ET . , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090811/NE59652LOGO ) , , ... Ferrara , President and Chief Executive Officer, and Peter F. Byczko , Vice ...
... PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing ... Company,s Interim CEO, Eric I. Richman , will be participating ... government, academia and industry in the development of medical countermeasures vital ... , , ...
... like a piece of gel that slips into the sole ... can make computers and the Internet hundreds of times faster ... only five or ten years in the future, currently being ... of Electrical Engineering. Dr. Scheuer has developed a ...
Cached Biology Technology:Microfluidics International Corporation to Report First Quarter 2010 Financial Results on May 11, 2010 2Microfluidics International Corporation to Report First Quarter 2010 Financial Results on May 11, 2010 3PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference 2An optical traffic cop for rapid communication 2
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... PROVIDENCE, R.I. [Brown University] Global warming may exact ... new research shows that one key constituent of marshes ... zones of salt marshes. Despite the stresses associated with ... Keryn Gedan, a graduate student and salt marsh expert ...
... Federal Bureau of Investigation (FBI) has awarded Lockheed Martin ... contract to continue managing the FBI Criminal Justice Information ... contract covers the conversion of paper fingerprint, palm print ... FBI. , , Records processed through this ...
... Technology, an award-winning biometric technology research and development ... agreement with ACS Technologies, the leading provider of ... and other faith-based organizations. , , Through ... be offering Bio-SnapON(TM), a robust biometric identification system ...
Cached Biology News:Climate change may spell demise of key salt marsh constituent 2Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 2ACS Technologies(TM) Selects M2SYS for Innovative Biometric Software 2
... (RNase III) from E. coli is an ... to dsRNA fragments that have 2-base, 3'-overhangs. ... dsRNA fragments of 12-15 bp. RNase ... canonical ribonucleotides as well as DuraScript™ RNA, ...
Rabbit polyclonal to Peptide E ( Abpromise for all tested applications)....
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
...
Biology Products: